Why is Caplin Point Lab falling/rising?

As of 15-Sep, Caplin Point Laboratories Ltd's stock price is currently at Rs 2,276.50, reflecting an increase of Rs 35.8 or 1.6%. The stock has shown strong performance recently, gaining 7.69% over the last seven days and outperforming its sector by 2.05% today. It has consistently traded above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. The company has also reported impressive financial results, with net sales and profit after tax reaching their highest levels in recent quarters. Additionally, the stock has demonstrated consistent returns over the past three years, outperforming the broader market, which has likely bolstered investor confidence.
In the broader market context, Caplin Point Laboratories has outperformed the Sensex in the short term, with a 4.71% return over the past week compared to the Sensex's 1.24%. This trend of outperformance is further supported by increasing participation from institutional investors, who have raised their stake in the company, indicating a positive outlook on its fundamentals. The company's low debt-to-equity ratio and high management efficiency, reflected in a return on equity of 19.84%, contribute to its favorable position in the market. Overall, the combination of strong financial performance, positive investor sentiment, and consistent returns has contributed to the stock's rising price.